Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vaxcyte, Inc.

35.39
+0.15000.43%
Pre-market: 35.400.0100+0.03%05:49 EDT
Volume:1.94M
Turnover:69.58M
Market Cap:4.57B
PE:-9.31
High:36.71
Open:35.75
Low:34.90
Close:35.24
Loading ...

Vaxcyte Appoints DR. Olivier Brandicourt to Board of Directors

THOMSON REUTERS
·
01 May

Press Release: Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

Dow Jones
·
01 May

Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom -- Barrons.com

Dow Jones
·
22 Apr

Vaxcyte Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
22 Apr

Vaxcyte initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
22 Apr

Vaxcyte, Inc. (PCVX): Billionaire Stanley Druckenmiller’s Top Stock Pick with Huge Upside Potential

Insider Monkey
·
12 Apr

Vaxcyte Stock Plummets 56% in a Month: Here's the Reason

Zacks
·
11 Apr

Vaxcyte Price Target Maintained With a $90.00/Share by Needham

Dow Jones
·
08 Apr

Small U.S. Stocks End Mixed As CoreWeave Cl A Lead, Vaxcyte Lags

Dow Jones
·
02 Apr

BUZZ-Vaxcyte down after Leerink's PT cut

Reuters
·
01 Apr

Vaxcyte Inc : Bofa Global Research Cuts Price Objective to $137 From $157

THOMSON REUTERS
·
01 Apr

Vaxcyte Is Maintained at Buy by Needham

Dow Jones
·
01 Apr

Vaxcyte price target lowered to $90 from $140 at Needham

TIPRANKS
·
01 Apr

Needham Cuts Price Target on Vaxcyte to $90 From $140, Maintains Buy Rating

MT Newswires Live
·
01 Apr

Vaxcyte’s VAX-24: Promising Infant Vaccine Results Amidst Investor Concerns

TIPRANKS
·
01 Apr

Optimistic Outlook for Vaxcyte: Potential for Improved Vaccine Efficacy in Future Trials

TIPRANKS
·
01 Apr

Vaxcyte ‘narrow’ misses in Phase 2 likely to be ok in Phase 3, says Evercore ISI

TIPRANKS
·
01 Apr

BUZZ-Vaxcyte falls as pneumococcal vaccine data fails to meet lofty investor expectations

Reuters
·
01 Apr

Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet

Benzinga
·
31 Mar

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

Dow Jones
·
31 Mar